Early Phase 1 Tolerance Clinical Trials

4 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–4 of 4 trials

Recruiting

Early Phase 1

PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults

Pain, ToleranceOral vs Vaporized THCAbuse Liability

Yale University20 enrolled1 locationNCT05906511

Recruiting

Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more

Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069

Recruiting

Early Phase 1

Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

Diabetes Mellitus, Type 2Impaired Glucose Tolerance

Tongji Hospital84 enrolled1 locationNCT06964620

Recruiting

Early Phase 1

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Safety IssuesTolerance

Kariya Pharmaceuticals88 enrolled1 locationNCT06189170